A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial

被引：8

作者：

Bosaeed, Mohammad ^{[1
,2
,3
]}

Mahmoud, Ebrahim ^{[1
]}

Hussein, Mohammad ^{[3
]}

Alharbi, Ahmad ^{[1
]}

Alsaedy, Abdulrahman ^{[1
,2
]}

Alothman, Adel ^{[1
,2
]}

Aljeraisy, Majed ^{[3
,4
]}

Alqahtani, Hajar ^{[4
]}

Nashabat, Marwan ^{[3
]}

Almutairi, Badriah ^{[3
]}

Almaghaslah, Manar ^{[1
]}

Aldibasi, Omar ^{[3
]}

AlJohani, Sameera ^{[2
,3
]}

Bouchama, Abderrezak ^{[3
,5
]}

Arabi, Yaseen ^{[2
,5
]}

Alaskar, Ahmad ^{[2
,3
]}

机构：

[1] King Abdul Aziz Med City, Dept Med, Riyadh, Saudi Arabia

[2] King Saud bin Abdulaziz Univ Hlth Sci, Coll Med, Riyadh, Saudi Arabia

[3] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia

[4] King Abdul Aziz Med City, Pharmaceut Care Dept, Riyadh, Saudi Arabia

[5] King Abdul Aziz Med City, Intens Care Dept, Riyadh, Saudi Arabia

来源：

TRIALS | 2020年 / 21卷 / 01期

关键词：

COVID-19; Randomised controlled trial; protocol; Favipiravir; Hydroxychloroquine; Saudi Arabia;

D O I：

10.1186/s13063-020-04825-x

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页数：3

共 50 条

[1] A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial
Mohammad Bosaeed
Ebrahim Mahmoud
Mohammad Hussein
Ahmad Alharbi
Abdulrahman Alsaedy
Adel Alothman
Majed Aljeraisy
Hajar Alqahtani
Marwan Nashabat
Badriah Almutairi
Manar Almaghaslah
Omar Aldibasi
Sameera AlJohani
Abderrezak Bouchama
Yaseen Arabi
Ahmad Alaskar
[J]. Trials, 21
[2] Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Emadi, Ashkan
Chua, Joel V.
Talwani, Rohit
Bentzen, Soren M.
Baddley, John
[J]. TRIALS, 2020, 21 (01)
[3] Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Ashkan Emadi
Joel V. Chua
Rohit Talwani
Søren M. Bentzen
John Baddley
[J]. Trials, 21
[4] The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
Samimagham, Hamid Reza
Azad, Mehdi Hassani
Haddad, Maryam
Arabi, Mohsen
Hooshyar, Dariush
KazemiJahromi, Mitra
[J]. TRIALS, 2020, 21 (01)
[5] The Efficacy of Famotidine in improvement of outcomes in Hospitalized COVID-19 Patients: A structured summary of a study protocol for a randomised controlled trial
Hamid Reza Samimagham
Mehdi Hassani Azad
Maryam Haddad
Mohsen Arabi
Dariush Hooshyar
Mitra KazemiJahromi
[J]. Trials, 21
[6] Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial
Abolghasem Allahyari
Hossein Rahimi
Majid Khadem-Rezaiyan
Zahra Mozaheb
Mohsen Seddigh-Shamsi
Alireza Bary
Mostafa Kamandi
Sajad Ataei Azimi
Saeed Eslami HasanAbadi
Alireza Noferesti
Somayeh Sadat Shariatmaghani
Houshang Rafatpanah
Shohreh Khatami
Afshin Jabbar Imani
Hassan Mortazi
Mohammad Moeini Nodeh
[J]. Trials, 21
[7] Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: a structured summary of a study protocol for a randomised controlled trial
Allahyari, Abolghasem
Rahimi, Hossein
Khadem-Rezaiyan, Majid
Mozaheb, Zahra
Seddigh-Shamsi, Mohsen
Bary, Alireza
Kamandi, Mostafa
Azimi, Sajad Ataei
HasanAbadi, Saeed Eslami
Noferesti, Alireza
Shariatmaghani, Somayeh Sadat
Rafatpanah, Houshang
Khatami, Shohreh
Imani, Afshin Jabbar
Mortazi, Hassan
Nodeh, Mohammad Moeini
[J]. TRIALS, 2020, 21 (01)
[8] Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
Bosaeed, Mohammad
Mahmoud, Ebrahim
Alharbi, Ahmad
Altayib, Hadeel
Albayat, Hawra
Alharbi, Faisal
Ghalilah, Khalid
Al Arfaj, Abdulmajid
AlJishi, Jumana
Alarfaj, Abdullatif
Alqahtani, Hajar
Almutairi, Badriah M.
Almaghaslah, Manar
Alyahya, Nawaf M.
Bawazir, Abdullah
AlEisa, Saud
Alsaedy, Abdulrahman
Bouchama, Abderrezak
Alharbi, Malak
AlShamrani, Majid
Al Johani, Sameera
Aljeraisy, Majed
Alzahrani, Mohammed
Althaqafi, Abdulhakeem O.
Almarhabi, Hassan
Alotaibi, Athari
Alqahtani, Nasser
Arabi, Yaseen M.
Aldibasi, Omar S.
Alaskar, Ahmad
[J]. INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2291 - 2307
[9] Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial
Mohammad Bosaeed
Ebrahim Mahmoud
Ahmad Alharbi
Hadeel Altayib
Hawra Albayat
Faisal Alharbi
Khalid Ghalilah
Abdulmajid Al Arfaj
Jumana AlJishi
Abdullatif Alarfaj
Hajar Alqahtani
Badriah M. Almutairi
Manar Almaghaslah
Nawaf M. Alyahya
Abdullah Bawazir
Saud AlEisa
Abdulrahman Alsaedy
Abderrezak Bouchama
Malak Alharbi
Majid AlShamrani
Sameera Al Johani
Majed Aljeraisy
Mohammed Alzahrani
Abdulhakeem O. Althaqafi
Hassan Almarhabi
Athari Alotaibi
Nasser Alqahtani
Yaseen M. Arabi
Omar S. Aldibasi
Ahmad Alaskar
[J]. Infectious Diseases and Therapy, 2021, 10 : 2291 - 2307
[10] Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial
Pourdowlat, Guitti
Mousavinasab, Seyed Ruhollah
Farzanegan, Behrooz
Kashefizadeh, Alireza
Meybodi, Zohreh Akhoundi
Jafarzadeh, Maedeh
Baniasadi, Shadi
[J]. TRIALS, 2021, 22 (01)

← 1 2 3 4 5 →